Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:46 UTC |
---|
HMDB ID | HMDB0014884 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Deferoxamine |
---|
Description | Deferoxamine is only found in individuals that have used or taken this drug. It is a natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. [PubChem]Deferoxamine works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming ferrioxamine, a stable complex which is eliminated via the kidneys. 100 mg of deferoxamine is capable of binding approximately 8.5 mg of trivalent (ferric) iron. Deferoxamine works in treating aluminum toxicity by binding to tissue-bound aluminum to form aluminoxamine, a stable, water-soluble complex. The formation of aluminoxamine increases blood concentrations of aluminum, resulting in an increased concentration gradient between the blood and dialysate, boosting the removal of aluminum during dialysis. 100 mg of deferoxamine is capable of binding approximately 4.1 mg of aluminum. |
---|
Structure | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34) |
---|
Synonyms | Value | Source |
---|
Deferoxamin | ChEBI | Deferoxamina | ChEBI | Deferoxaminum | ChEBI | Deferrioxamine | ChEBI | Deferrioxamine b | ChEBI | Desferrioxamine | ChEBI | DFO | ChEBI | Deferoxamide b | HMDB | Deferoxamine b | HMDB | Desferrioxamine b | HMDB | DF b | HMDB | DFOA | HMDB | DFOM | HMDB | N-Benzoylferrioxamine b | HMDB | b, Deferoxamine | HMDB | Deferoxamine mesylate | HMDB | Deferoximine | HMDB | Desferioximine | HMDB | Desferrioxamine b mesylate | HMDB | Mesylate, deferoxamine | HMDB | Deferoxamine methanesulfonate | HMDB | Mesylate, desferrioxamine b | HMDB | Methanesulfonate, deferoxamine | HMDB | b, Desferrioxamine | HMDB | Desferal | HMDB | Mesilate, deferoxamine | HMDB | Deferoxamine mesilate | HMDB | Desferroxamine | HMDB |
|
---|
Chemical Formula | C25H48N6O8 |
---|
Average Molecular Weight | 560.684 |
---|
Monoisotopic Molecular Weight | 560.353362542 |
---|
IUPAC Name | N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]butanediamide |
---|
Traditional Name | N-(5-aminopentyl)-N-hydroxy-N'-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]carbamoyl}propanamido)pentyl]succinamide |
---|
CAS Registry Number | 70-51-9 |
---|
SMILES | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN |
---|
InChI Identifier | InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34) |
---|
InChI Key | UBQYURCVBFRUQT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as acetohydroxamic acids. These are organic compounds that contain a hydroxamic acid group carrying a methyl group attached to its carbon center. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Carboxylic acid derivatives |
---|
Direct Parent | Acetohydroxamic acids |
---|
Alternative Parents | |
---|
Substituents | - Acetamide
- Acetohydroxamic acid
- Amino acid or derivatives
- Carboximidic acid
- Carboximidic acid derivative
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Carbonyl group
- Organic nitrogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Amine
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 138 - 140 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.099 g/L | Not Available | LogP | -2.2 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Deferoxamine,1TMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C | 5278.3 | Semi standard non polar | 33892256 | Deferoxamine,1TMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C | 4808.9 | Standard non polar | 33892256 | Deferoxamine,1TMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C | 7605.1 | Standard polar | 33892256 | Deferoxamine,1TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 5099.5 | Semi standard non polar | 33892256 | Deferoxamine,1TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 4596.7 | Standard non polar | 33892256 | Deferoxamine,1TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 7964.8 | Standard polar | 33892256 | Deferoxamine,1TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 5098.7 | Semi standard non polar | 33892256 | Deferoxamine,1TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 4596.4 | Standard non polar | 33892256 | Deferoxamine,1TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C | 7964.7 | Standard polar | 33892256 | Deferoxamine,2TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 5137.8 | Semi standard non polar | 33892256 | Deferoxamine,2TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 4723.6 | Standard non polar | 33892256 | Deferoxamine,2TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 7057.3 | Standard polar | 33892256 | Deferoxamine,2TMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 5137.6 | Semi standard non polar | 33892256 | Deferoxamine,2TMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 4722.9 | Standard non polar | 33892256 | Deferoxamine,2TMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C | 7057.2 | Standard polar | 33892256 | Deferoxamine,2TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C | 5382.4 | Semi standard non polar | 33892256 | Deferoxamine,2TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C | 4752.8 | Standard non polar | 33892256 | Deferoxamine,2TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C | 7060.4 | Standard polar | 33892256 | Deferoxamine,2TMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C)[Si](C)(C)C | 4915.6 | Semi standard non polar | 33892256 | Deferoxamine,2TMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C)[Si](C)(C)C | 4527.6 | Standard non polar | 33892256 | Deferoxamine,2TMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C)[Si](C)(C)C | 7528.4 | Standard polar | 33892256 | Deferoxamine,3TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4929.8 | Semi standard non polar | 33892256 | Deferoxamine,3TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4652.0 | Standard non polar | 33892256 | Deferoxamine,3TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 6611.6 | Standard polar | 33892256 | Deferoxamine,3TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 5205.7 | Semi standard non polar | 33892256 | Deferoxamine,3TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4699.0 | Standard non polar | 33892256 | Deferoxamine,3TMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 6631.1 | Standard polar | 33892256 | Deferoxamine,3TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 5206.9 | Semi standard non polar | 33892256 | Deferoxamine,3TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4698.6 | Standard non polar | 33892256 | Deferoxamine,3TMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 6631.2 | Standard polar | 33892256 | Deferoxamine,4TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 5059.2 | Semi standard non polar | 33892256 | Deferoxamine,4TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 4644.4 | Standard non polar | 33892256 | Deferoxamine,4TMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 6274.9 | Standard polar | 33892256 | Deferoxamine,1TBDMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C | 5521.9 | Semi standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C | 4928.7 | Standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #1 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C | 7290.2 | Standard polar | 33892256 | Deferoxamine,1TBDMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 5307.9 | Semi standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 4742.9 | Standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #2 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 7703.5 | Standard polar | 33892256 | Deferoxamine,1TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 5307.2 | Semi standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 4742.4 | Standard non polar | 33892256 | Deferoxamine,1TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C | 7703.5 | Standard polar | 33892256 | Deferoxamine,2TBDMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5618.7 | Semi standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4984.7 | Standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #1 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6706.6 | Standard polar | 33892256 | Deferoxamine,2TBDMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5619.0 | Semi standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4984.5 | Standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #2 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6706.6 | Standard polar | 33892256 | Deferoxamine,2TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5762.0 | Semi standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5042.9 | Standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #3 | CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6737.0 | Standard polar | 33892256 | Deferoxamine,2TBDMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5342.5 | Semi standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4834.9 | Standard non polar | 33892256 | Deferoxamine,2TBDMS,isomer #4 | CC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN(C(=O)CCC(=O)N(O)CCCCCN)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 7163.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Deferoxamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0uyu-9351600000-db7e9dcd06da7cb8ce44 | 2017-09-01 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine DI-ESI-Hybrid FT , Positive-QTOF | splash10-00di-2901000023-e1b4c2a4d54a44d851b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine LC-ESI-Hybrid FT , Positive-QTOF | splash10-0007-9621400000-89d305f0c72708d1a2e9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine LC-ESI-qTof , Positive-QTOF | splash10-0udl-0892110000-487a5822b41da03f0948 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine , negative-QTOF | splash10-05ne-1943110000-cfdaf16ce07341d78b59 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine , positive-QTOF | splash10-0udl-0892110000-487a5822b41da03f0948 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine , positive-QTOF | splash10-0007-9621400000-9b6a525f53e7f320f714 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine , positive-QTOF | splash10-0ikc-1771190000-39b4db7f6f66f4b9474e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Deferoxamine , positive-QTOF | splash10-001i-0111190000-7dabe399b61bdc270ec0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 10V, Positive-QTOF | splash10-066r-0914140000-564eef1c4ca4057e0567 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 20V, Positive-QTOF | splash10-066r-3912000000-9d41fb6ae4247de66ef2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 40V, Positive-QTOF | splash10-067i-4911000000-7819a57b67abf35540d3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 10V, Negative-QTOF | splash10-0ab9-3141590000-a67788337266f4e2e5e5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 20V, Negative-QTOF | splash10-01bc-6675890000-824c1c1e5fffa6d72d90 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 40V, Negative-QTOF | splash10-00kb-7977400000-661b6336ef20e2b1ba69 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 10V, Positive-QTOF | splash10-03dr-0010490000-e97a2d4dca00e317a41e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 20V, Positive-QTOF | splash10-0f79-1122920000-ce9d5dfc81809a482de9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 40V, Positive-QTOF | splash10-0udi-4691200000-79dab384d40c3ad05578 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 10V, Negative-QTOF | splash10-05fr-9201280000-5cd6e34dc196f2e5d980 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 20V, Negative-QTOF | splash10-05fr-9402330000-6beb4fc412e7f849419c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Deferoxamine 40V, Negative-QTOF | splash10-014j-4932200000-c770808cdf01ec543d6f | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|